Anyone requiring surgery due to Mirena side effects is urged to visit the DrugRisk Resource Center or speak with a lawyer about their legal options as soon as possible.
Dallas, TX (PRWEB) December 04, 2012
The Food and Drug Administration has so far received over 45,000 reports of women using the IUD contraceptive Mirena suffering complications, according to the Adverse Events Report on November 20th tracking FDA AERS reports since approval in 2000.
Among these, the most common reported Mirena side effects were device expulsion, device dislocation and vaginal hemorrhage. In more than 6% of cases, patients required hospitalization or surgery.
Now, a patient claiming she suffered injury from using Mirena has joined the litigation against Bayer. A woman filed suit on November 5th alleging she had to undergo surgery after the device dislocated and caused extreme pain. MRS-L-2723-12, New Jersey Morris County Superior Court, Judge Stephan Hansbury.
Lawyers are helping those affected learn their rights. Anyone requiring surgery due to Mirena side effects is urged to visit the DrugRisk Resource Center or speak with a lawyer about their legal options and a potential Mirena lawsuit as soon as possible.
In 2009, the FDA warned Bayer about the marketing of Mirena, which failed to disclose safety risks while claiming the devices could help busy moms with intimacy and make them “look and feel great.”*
Now, in order to handle the volume of Mirena lawsuits expected, Bayer recently petitioned for cases to be consolidated to the New Jersey Superior Court in Middlesex County, where the company is headquartered.**
Anyone affected by a Mirena device is urged to learn about their legal rights to file a claim. Due to the specialized nature of medical device injury cases, the Drug Risk Resource Center only recommends lawyers who are already handling Mirena lawsuits.
For more information on the research, side effects and litigation news related to Mirena and other medical devices, or to speak with a lawyer, visit http://www.DrugRisk.com.
*NDA 21-225, Mirena (levonorgestrel-releasing intrauterine system) MACMIS # 18166, 12/30/09